IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ODICINO, Franco Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.589
EU - Europa 5.894
AS - Asia 5.594
SA - Sud America 877
Continente sconosciuto - Info sul continente non disponibili 489
AF - Africa 160
OC - Oceania 76
AN - Antartide 1
Totale 23.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.288
IT - Italia 2.382
SG - Singapore 1.859
CN - Cina 1.528
BR - Brasile 719
UA - Ucraina 655
HK - Hong Kong 595
PL - Polonia 504
DE - Germania 500
BD - Bangladesh 454
GB - Regno Unito 352
VN - Vietnam 317
FI - Finlandia 298
FR - Francia 263
TR - Turchia 210
RU - Federazione Russa 190
IN - India 186
CA - Canada 170
IE - Irlanda 151
CH - Svizzera 146
ES - Italia 90
ID - Indonesia 84
NL - Olanda 68
SE - Svezia 68
MX - Messico 67
AU - Australia 60
AR - Argentina 59
JP - Giappone 58
IQ - Iraq 55
ZA - Sudafrica 53
EE - Estonia 49
SA - Arabia Saudita 42
MY - Malesia 23
EC - Ecuador 22
AT - Austria 20
LT - Lituania 19
MA - Marocco 19
PH - Filippine 19
PK - Pakistan 19
UZ - Uzbekistan 18
CZ - Repubblica Ceca 17
BE - Belgio 15
CL - Cile 15
PE - Perù 15
PT - Portogallo 15
JO - Giordania 14
NZ - Nuova Zelanda 14
AE - Emirati Arabi Uniti 13
CO - Colombia 13
CR - Costa Rica 13
EG - Egitto 13
JM - Giamaica 13
KE - Kenya 13
LI - Liechtenstein 13
VE - Venezuela 13
DZ - Algeria 11
NP - Nepal 11
AZ - Azerbaigian 10
LU - Lussemburgo 10
BG - Bulgaria 9
IL - Israele 9
SK - Slovacchia (Repubblica Slovacca) 9
TN - Tunisia 9
BO - Bolivia 8
KR - Corea 8
KZ - Kazakistan 8
PY - Paraguay 8
AL - Albania 7
ET - Etiopia 7
MK - Macedonia 7
TH - Thailandia 7
BH - Bahrain 6
DK - Danimarca 6
GT - Guatemala 6
IR - Iran 6
NG - Nigeria 6
OM - Oman 6
UG - Uganda 6
EU - Europa 5
GH - Ghana 5
GR - Grecia 5
HN - Honduras 5
KG - Kirghizistan 5
UY - Uruguay 5
LK - Sri Lanka 4
LV - Lettonia 4
MU - Mauritius 4
NI - Nicaragua 4
PS - Palestinian Territory 4
RO - Romania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BS - Bahamas 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
IS - Islanda 3
TW - Taiwan 3
AM - Armenia 2
CM - Camerun 2
Totale 23.152
Salva come PNG Salva come JPEG
Città #
Ashburn 1.089
Singapore 947
Fairfield 913
Woodbridge 768
Hong Kong 586
San Jose 500
Houston 490
Warsaw 485
Jacksonville 445
Seattle 386
Wilmington 384
New York 380
Chandler 344
Beijing 341
Ann Arbor 338
Cambridge 327
Los Angeles 264
The Dalles 253
Princeton 239
Milan 205
Dearborn 169
Brescia 166
Helsinki 165
Nanjing 158
Lauterbourg 149
Dublin 148
Istanbul 140
Council Bluffs 132
Munich 122
Ho Chi Minh City 115
Dallas 103
London 102
Rome 101
Des Moines 99
Santa Clara 98
Chicago 96
Buffalo 92
Zurich 90
Moscow 89
Columbus 87
San Francisco 78
São Paulo 75
Redondo Beach 68
Shanghai 67
Boardman 64
Hanoi 63
Toronto 53
Shenyang 51
Nanchang 49
Tallinn 49
Jakarta 47
Changsha 43
Hangzhou 42
Orem 42
San Diego 42
Frankfurt am Main 40
Hebei 40
Chennai 38
Denver 38
Montreal 37
Tokyo 37
Tianjin 36
Stockholm 34
Turku 33
Jinan 32
Charlotte 31
Johannesburg 31
Brooklyn 30
Guangzhou 29
Jiaxing 29
Nuremberg 28
Poplar 28
Melbourne 27
Turin 27
Kunming 25
Boston 24
Paris 24
Mexico City 23
Phoenix 23
Naples 22
Dhaka 21
Romola 21
Dong Ket 20
Pune 20
Verona 20
Washington 20
Lappeenranta 19
Ankara 18
Atlanta 18
Baghdad 18
Belo Horizonte 18
Manchester 18
Mumbai 17
Genoa 16
Pleasanton 16
Amsterdam 15
Bologna 15
Brasília 15
Dalmine 15
Hefei 15
Totale 14.059
Salva come PNG Salva come JPEG
Nome #
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 2.934
Preeclampsia and late fetal growth restriction 404
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 364
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 332
Claudin3 is localized outside the tight junctions in human carcinomas 298
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 288
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 221
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 211
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 206
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 202
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 193
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 188
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): Case Report and Systematic Literature Review 183
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 180
Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas 180
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 177
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 177
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 175
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 172
Consolidation therapies revisited: weekly paclitaxel 170
Carcinoma of the Fallopian tube 165
Clinical and prognostic value of 18 F-FDG PET/CT in recurrent endometrial carcinoma 164
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study 159
Treatment of Early Cesarean Scar Pregnancy with Double Balloon Catheter: A Systematic Review of the Literature 155
Carcinoma of the corpus uteri 155
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 153
Carcinoma of the Fallopian tube 151
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 150
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers 149
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 147
Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP) 146
Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasia. 146
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience 145
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 145
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 145
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 144
Early stage ovarian cancer: the Italian contribution to clinical research. An update 143
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 143
Clear cell degeneration associated with endometriosis of abdominal wall after cesarean section: A case report and systematic review of literature 143
Replacement therapy for breast cancer survivors. A pilot study 142
Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection 142
Staging classification for cancer of the ovary, fallopian tube, and peritoneum 141
New development of the FIGO staging system. 138
Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 138
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 138
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 138
Carcinoma of the fallopian tube. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 137
Interval debulking surgery in advanced epithelial ovarian cancer 136
Carcinoma of the corpus uteri 136
Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 135
Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium 135
Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection 134
Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study 134
Gestational trophoblastic diseases 134
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 134
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 134
Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity 132
null 132
Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic Oncology 132
History of the FIGO cancer staging system 131
Five-year follow-up of placental involution after abdominal pregnancy 131
Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium 128
Gestational trophoblastic diseases 128
Carcinoma of the cervix uteri 127
Hormone replacement therapy in breast cancer 127
Systemic therapy for gynecological neoplasms: ovary, cervix, and endometrium. 126
Ultrasound examination in ovarian cancer patients. A comparison with second look laparotomy 126
Staging of gynecologic malignancies 126
Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer: a systematic review and meta-analysis 123
Carcinoma of the ovary 123
Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 123
Uterine sarcomas: a clinicopathologic study 123
Carcinoma of the ovary 123
Early non-compliance to ERAS in gynecological open surgery for malignancies, and post-operative complications: a multicenter, prospective, observational, cohort study 122
Optimizing gemcitabine regimens in ovarian cancer. 122
Carcinoma of the vagina 122
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimens 122
Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer? 121
Revised FIGO staging for carcinoma of the cervix. 121
Carcinoma of the cervix uteri 121
Ovarial cancer: best timing and applications of debulking surgery 120
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 120
Integrated mutational landscape analysis of uterine leiomyosarcomas 118
Crossover study with cisplatin or carboplatin in advanced ovarian cancer 118
Cancer in women 118
Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship 118
Chronic hypertension in pregnancy: insights into adverse outcomes prevention 118
Real World Application of Chemotherapy Response Score in High Grade Serous Cancer of the Ovary 117
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 115
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology. 115
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 115
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy 113
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 113
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group) 112
Carcinoma of the vagina 112
Carcinoma of the vulva 111
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 111
Cold Knife Versus Carbon Dioxide for the Treatment of Preinvasive Cervical Lesion 110
Totale 17.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.029
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022954 0 157 6 43 3 51 105 70 48 122 96 253
2022/20232.139 159 59 207 274 229 283 67 148 193 128 211 181
2023/20242.370 177 106 201 159 209 375 137 183 361 245 45 172
2024/20253.500 41 109 93 465 302 309 321 142 386 250 650 432
2025/20267.248 676 825 442 819 724 463 1.070 343 419 623 446 398
2026/2027595 373 222 0 0 0 0 0 0 0 0 0 0
Totale 23.680